INITIAL CLINICAL PRESENTATION IN CASES OF INBORN ERRORS OF METABOLISM IN A REFERENCE CHILDREN'S HOSPITAL: STILL A

Andressa Romão1, Priscila Endlich Alves Simon2, José Eduardo Coutinho Góes3

  • 1Hospital Ministro Costa Cavalcanti, Foz do Iguaçu, PR, Brasil.

Insights

Inborn errors of metabolism (IEM) present significant diagnostic challenges in pediatrics. Early identification of IEM symptoms like cognitive impairment and seizures is crucial for effective treatment and preventing long-term health issues.

Area of Science:

  • Pediatric Medicine
  • Clinical Genetics
  • Metabolic Disorders

Background:

  • Inborn errors of metabolism (IEM) are a group of genetic disorders that disrupt metabolic pathways.
  • Accurate and timely diagnosis of IEM is essential for effective management and prevention of severe complications.
  • Pediatric reference facilities play a critical role in identifying and managing complex pediatric conditions like IEM.

Purpose of the Study:

  • To characterize the initial clinical presentation of patients investigated for inborn errors of metabolism (IEM).
  • To identify common signs, symptoms, and laboratory findings associated with confirmed IEM cases.
  • To understand the diagnostic challenges faced in pediatric practice regarding IEM.

Main Methods:

  • A cross-sectional, observational study was conducted from January 2009 to December 2013.
  • Data were collected from 144 pediatric outpatients referred for IEM investigation.
  • Variables included clinical presentation, family history, and laboratory abnormalities; descriptive statistics were used.

Main Results:

  • Of 144 patients, 8.3% were diagnosed with IEM, including aminoacidopathies, organic acidemias, urea cycle disorders, and lysosomal storage diseases.
  • The most common initial signs and symptoms were cognitive impairment, seizures, growth retardation, and developmental delay.
  • Key laboratory findings included hyperammonemia and metabolic acidosis.

Conclusions:

  • Diagnosing IEM in pediatric practice remains challenging due to limited access to specialized tests, a shortage of experts, and insufficient knowledge dissemination.
  • Early recognition of IEM, considering factors like cognitive impairment and seizures, is vital for timely intervention.
  • Prompt diagnosis significantly impacts treatment outcomes and the prevention of sequelae in children with IEM.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
937
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
276
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
351
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
302